You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

Details for Patent: 10,350,214

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,350,214 protect, and when does it expire?

Patent 10,350,214 protects ALECENSA and is included in one NDA.

This patent has thirty-eight patent family members in seventeen countries.

Summary for Patent: 10,350,214

Scope and claims summary:

Title:	Preparation containing tetracyclic compound at high dose
Abstract:	An improved solubility of a pharmaceutical composition or formulation containing a large amount of 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihy- dro-5H-benzo[b]carbazole-3-carbonitrile or a salt thereof can be achieved by forming granules of the compound or salt thereof and allowing the granules to be present together with a disintegrating agent.
Inventor(s):	Tomimatsu; Takashi (Tokyo, JP), Okazaki; Kensuke (Tokyo, JP), Ogawa; Yumi (Tokyo, JP), Yamamura; Takahiro (Tokyo, JP)
Assignee:	CHUGAI SEIYAKU KABUSHIKI KAISHA (Tokyo, JP)
Application Number:	15/304,133
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Compound;

Drugs Protected by US Patent 10,350,214

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Hoffmann-la Roche	ALECENSA	alectinib hydrochloride	CAPSULE;ORAL	208434-001	Dec 11, 2015		RX	Yes	Yes	10,350,214	⤷ Subscribe	Y				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 10,350,214

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	2014-092101	Apr 25, 2014

PCT Information
PCT Filed	April 24, 2015	PCT Application Number:	PCT/JP2015/062520
PCT Publication Date:	October 29, 2015	PCT Publication Number:	WO2015/163448

International Family Members for US Patent 10,350,214

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	100187	⤷ Subscribe
Australia	2015250574	⤷ Subscribe
Australia	2020230293	⤷ Subscribe
Brazil	112016021206	⤷ Subscribe
Canada	2946518	⤷ Subscribe
Canada	3140565	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.